ICU Medical
ICU Medical, Inc., headquartered in the United States, is a leading player in the medical device industry, specialising in innovative infusion therapy and critical care solutions. Founded in 1984, the company has achieved significant milestones, including the development of advanced safety systems that enhance patient care and reduce the risk of medication errors. With a strong presence in North America and expanding operations globally, ICU Medical offers a diverse range of products, including infusion pumps, IV solutions, and customisable software. Their unique focus on integrating technology with clinical practice sets them apart in the market. Recognised for their commitment to quality and safety, ICU Medical has garnered numerous accolades, solidifying their position as a trusted partner in healthcare.
DitchCarbon Score
How does ICU Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ICU Medical's score of 27 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ICU Medical's reported carbon emissions
In 2023, ICU Medical reported total carbon emissions of approximately 44,110 kg CO2e, with emissions distributed across various scopes. Specifically, Scope 1 emissions accounted for about 420 kg CO2e, while Scope 2 emissions were approximately 710 kg CO2e. The majority of emissions stemmed from Scope 3, totalling around 41,980 kg CO2e, which included significant contributions from business travel (about 20,720 kg CO2e) and downstream transportation and distribution (approximately 20,780 kg CO2e). ICU Medical has set ambitious climate commitments, aiming for Net Zero emissions by 2050 in the United Kingdom. The company has established a near-term target to reduce its Scope 3 emissions by 25% by 2030, using 2022 as a baseline. This commitment reflects a proactive approach to addressing climate change and aligns with industry standards for sustainability and carbon reduction.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ICU Medical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
